Delandistrogene moxeparvovec, sold under the brand name Elevidys, is a recombinant gene therapy used for the treatment of Duchenne muscular dystrophy. From Wikipedia
The company is enhancing immunosuppressive regimens to address emerging safety signals in its Duchenne muscular dystrophy gene therapy
